FOLLICULAR LYMPHOMA GRADE 3A

Clinical trials for FOLLICULAR LYMPHOMA GRADE 3A explained in plain language.

Never miss a new study

Get alerted when new FOLLICULAR LYMPHOMA GRADE 3A trials appear

Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA GRADE 3A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat lymphoma: experimental pill shows promise

Disease control Recruiting now

This study tests an experimental drug called XNW5004 in 65 adults with follicular lymphoma (a slow-growing blood cancer) that has returned or stopped responding after at least three prior treatments. Participants take the drug twice daily for 28-day cycles. Researchers will measu…

Matched conditions: FOLLICULAR LYMPHOMA GRADE 3A

Phase: PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

FOLLICULAR LYMPHOMA GRADE 3A

Get alerted when new FOLLICULAR LYMPHOMA GRADE 3A trials appear

New hope for Tough-to-Treat lymphoma: experimental pill shows promise